BACKGROUND AND PURPOSE: Although a strong relationship has been established between vascular disease and cognitive decline, the current challenge is to identify vascular risk factors and mechanisms that are associated with cognitive function before the development of severe dysfunction (eg, vascular dementia). This study was conducted to determine the relationship between blood vessel function and cognition in elderly patients with atherosclerosis. METHODS: Participants were 14 elderly individuals with atherosclerotic vascular disease, who had no history of stroke, cardiac surgery, or dementia diagnosis. Forearm blood flow was measured before and after brachial artery infusion of 3 vasoactive agents (verapamil, acetylcholine, nitroprusside), and these measures of vessel function were then correlated with neuropsychological performance (total scale score on the Repeatable Battery for the Assessment of Neuropsychological Status). RESULTS: Positive correlations were found between neuropsychological performance and vasodilation in response to all 3 agents, with 2 reaching statistical significance (verapamil: rho=0.78, P=0.001; nitroprusside: rho=0.56, P=0.038) and the third showing a strong trend toward significance (acetylcholine: rho=0.49, P=0.076). Correlations between neuropsychological performance and more conventional vascular-related variables were much weaker. CONCLUSIONS: These data provide preliminary evidence of a relationship between resistance vessel function and neuropsychological performance. With further research, measures of vessel dysfunction may be useful in identifying individuals at risk for cognitive decline and vascular dementia.
BACKGROUND AND PURPOSE: Although a strong relationship has been established between vascular disease and cognitive decline, the current challenge is to identify vascular risk factors and mechanisms that are associated with cognitive function before the development of severe dysfunction (eg, vascular dementia). This study was conducted to determine the relationship between blood vessel function and cognition in elderly patients with atherosclerosis. METHODS:Participants were 14 elderly individuals with atherosclerotic vascular disease, who had no history of stroke, cardiac surgery, or dementia diagnosis. Forearm blood flow was measured before and after brachial artery infusion of 3 vasoactive agents (verapamil, acetylcholine, nitroprusside), and these measures of vessel function were then correlated with neuropsychological performance (total scale score on the Repeatable Battery for the Assessment of Neuropsychological Status). RESULTS: Positive correlations were found between neuropsychological performance and vasodilation in response to all 3 agents, with 2 reaching statistical significance (verapamil: rho=0.78, P=0.001; nitroprusside: rho=0.56, P=0.038) and the third showing a strong trend toward significance (acetylcholine: rho=0.49, P=0.076). Correlations between neuropsychological performance and more conventional vascular-related variables were much weaker. CONCLUSIONS: These data provide preliminary evidence of a relationship between resistance vessel function and neuropsychological performance. With further research, measures of vessel dysfunction may be useful in identifying individuals at risk for cognitive decline and vascular dementia.
Authors: David J Moser; Laura L Boles Ponto; Ivy N Miller; Susan K Schultz; Yusuf Menda; Stephan Arndt; Peggy C Nopoulos Journal: J Clin Exp Neuropsychol Date: 2011-12-13 Impact factor: 2.475
Authors: Karin F Hoth; David F Tate; Athena Poppas; Daniel E Forman; John Gunstad; David J Moser; Robert H Paul; Angela L Jefferson; Andreana P Haley; Ronald A Cohen Journal: Stroke Date: 2007-01-04 Impact factor: 7.914
Authors: Ronald A Cohen; Athena Poppas; Daniel E Forman; Karin F Hoth; Andreana P Haley; John Gunstad; Angela L Jefferson; David F Tate; Robert H Paul; Lawrence H Sweet; Mokato Ono; Beth A Jerskey; Marie Gerhard-Herman Journal: J Clin Exp Neuropsychol Date: 2008-06-16 Impact factor: 2.475
Authors: Daniel E Forman; Ronald A Cohen; Karin F Hoth; Andreana P Haley; Athena Poppas; David J Moser; John Gunstad; Robert H Paul; Angela L Jefferson; David F Tate; Makoto Ono; Nicole Wake; Marie Gerhard-Herman Journal: Artery Res Date: 2008-02-01 Impact factor: 0.597
Authors: Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Erica Y Griffith; Atul Narkhede; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: J Neurol Sci Date: 2013-03-23 Impact factor: 3.181
Authors: Michael L Alosco; Mary Beth Spitznagel; Manfred van Dulmen; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: J Aging Health Date: 2013-01-31
Authors: David J Moser; Ivy N Miller; Karin F Hoth; Marcelo Correia; Stephan Arndt; William G Haynes Journal: J Int Neuropsychol Soc Date: 2008-07 Impact factor: 2.892
Authors: Michael L Alosco; John Gunstad; Beth A Jerskey; Uraina S Clark; Jason J Hassenstab; Xiaomeng Xu; Athena Poppas; Ronald A Cohen; Lawrence H Sweet Journal: Int J Neurosci Date: 2013-03-14 Impact factor: 2.292
Authors: Anna L Macready; Orla B Kennedy; Judi A Ellis; Claire M Williams; Jeremy P E Spencer; Laurie T Butler Journal: Genes Nutr Date: 2009-08-13 Impact factor: 5.523
Authors: Patrick J Smith; James A Blumenthal; Michael A Babyak; Benson M Hoffman; P Murali Doraiswamy; Robert Waugh; Alan Hinderliter; Andrew Sherwood Journal: Psychosom Med Date: 2007-07-18 Impact factor: 4.312